(Q34736154)

4 August 2017

The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer (English)

1 reference

4 August 2017

1 reference

5

Grace Clarke Hillyer

1 reference

4 August 2017

1

Dawn L Hershman

1 reference

4 August 2017

6

Jason D Wright

1 reference

4 August 2017

7

Alfred I Neugut

1 reference

4 August 2017

Jennifer Tsui

2

1 reference

4 August 2017

Jay Meyer

series ordinal

3

1 reference

4 August 2017

Sherry Glied

series ordinal

4

1 reference

4 August 2017

language of work or name

English

0 references

publication date

27 October 2014

1 reference

Journal of the National Cancer Institute

4 August 2017

1 reference

4 August 2017

106

1 reference

4 August 2017

11

1 reference

Effects of Medicare Part D coverage gap on medication adherence

4 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adjuvant hormonal therapy use among insured, low-income women with breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

A review of interventions used to improve adherence to medication in older people

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Patient adherence and persistence with oral anticancer treatment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Interventions for enhancing medication adherence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence to endocrine therapy for breast cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence to tamoxifen over the five-year course

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence beliefs among breast cancer patients taking tamoxifen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Pharmacy benefits and the use of drugs by the chronically ill.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Mortality impact of less-than-standard therapy in older breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia--an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Cost-effectiveness of full coverage of aromatase inhibitors for Medicare beneficiaries with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Duration of adjuvant tamoxifen therapy.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4271034

Interventions to Improve Medication Adherence Among Older Adults: Meta-Analysis of Adherence Outcomes Among Randomized Controlled Trials

26 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJU319

Episode treatment groups: an illness classification and episode building system--Part I

21 January 2018

1 reference

12 December 2020

Episode treatment groups: an illness classification and episode building system--Part II

1 reference

12 December 2020

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group

1 reference

12 December 2020

Comments on Costs of treating advanced colorectal cancer, Ross et al., Eur J Cancer 1996, 32A, S13-S17

1 reference

12 December 2020

When will the U.S. flinch at cancer drug prices?

1 reference

12 December 2020

Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia

1 reference

12 December 2020

Increase in oral cancer drugs raises thorny issues for oncology practices

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJU319

1 reference

4 August 2017

1 reference

4 August 2017

1 reference